Zhejiang NHU Company Ltd.

$ 28.00 -1.75 %

Zhejiang NHU Company Ltd., founded in 1999 and headquartered in Xinchang, China, specializes in the nationwide production and distribution of a broad spectrum of chemical products. Its principal operations are divided into four main categories: 1. Nutritional Products: The company offers a comprehensive range of supplements, including essential vitamins (E, A, C, D3, biotin), DL-Methionine, coenzyme Q10, and various carotenoids. These ingredients are critical for enhancing animal feed and fortifying food, beverages, and health-related products. 2. Flavors and Fragrances: This segment supplies a variety of aroma chemicals, such as derivatives from the linalool and citral series, cis-3-hexenol, methyl dihydrojasmonate, raspberry ketone, and ligustral, which are widely utilized in personal care items, cosmetic formulations, and food flavorings. 3. New Polymer Materials: Zhejiang NHU provides advanced polymer solutions like polyphenylene sulfide and polyphthalamide. These materials find essential applications across industries including electronics, automotive manufacturing, and environmental protection. 4. Active Pharmaceutical Ingredients (APIs): The company manufactures crucial pharmaceutical components, including moxifloxacin hydrochloride, vitamin A, and vitamin D3, which serve as foundational substances for the development and production of various drug preparations.

CEO: Bai Shan Hu - https://www.cnhu.com

Price objectif

-

Recommandation

-

DCF

$ 38.07

Loading data...

002001.SZ vs S&P500

Loading data...

No data available.

Quick ratio

2.24

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

12.79

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

2.19

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

20.55 %

is generally considered excellent, indicating that the company is generating strong profits with its equity.

ROIC

15.25 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

5.68

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.22

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

2.28

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

35.10 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
7 indicates good financial health
Altman score
6.43 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
1.26 indicates that the company has sufficient cash to cover its short-term debts
Debt Ratio
0.16 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.